Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 03, 2012

K-V Pharmaceutical Company

Track this case

Case Number:

1:12-bk-13347

Court:

New York Southern

Nature of Suit:

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. September 24, 2012

    Bankrupt K-V Fights Hologic Bid To Reacquire Makena Rights

    Ailing drugmaker K-V Pharmaceutical Co. on Thursday told a New York federal judge that creditor Hologic Inc. is trying to skirt bankruptcy law by seeking worldwide rights to Makena, a drug that prevents premature birth, and is wrongly suggesting the potential blockbuster medicine is rapidly losing value.

3 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login